print this page
 

Franklin Moore, MD, PhD

 
Pathology Department
  • Assistant Professor of Pathology, Tufts University School of Medicine
  • Medical Director, Molecular and Microbiology
Address
Baystate Medical Center
Department of Pathology
759 Chestnut Street
Springfield, MA 01199
413.322.4712
franklin.moore@bhs.org
 
Education
  • Molecular Genetic Pathology Fellowship
    Oregon Health & Science University
    Portland, OR
  • Surgical Pathology Fellowship
    Oregon Health & Science University
    Portland, OR
  • Anatomic and Clinical Pathology
    Wake Forest University
    Winston-Salem, NC
  • Wayne State University
    Detroit, MI
  • PhD, Environmental Toxicology
    Cornell University
    Ithaca, NY
 
Areas of Interest
  • Molecular diagnostics of solid tumors and leukemias
  • Molecular virology
 
Committee Appointments
  • Member, Collaborative Biomedical Research Program Committee, Baystate
 
Publications

Chapters

  • Moore, F.R. and R.D. Press. 2011. Molecular Pathology of Solid Tumors.  In Essentials of Anatomic Pathology, 3rd ed, L. Cheng and D. Bostwick, eds.  Humana Press/Springer, New York, pp. 515-534.
  • Moore, F.R., C.B. Rempfer and R.D. Press.  2012.  The detection of BCR/ABL fusion transcripts at diagnosis and follow-up of chronic myelogenous leukemia.  In Methods in Molecular Biology, M. Czader, ed. Humana Press, New York (in press).
  • Moore, F.R., F. Yang and R.D. Press. 2012. Monitoring of imatinib resistance in chronic myelogenous leukemia.  In Methods in Molecular Biology, M. Czader, ed. Humana Press, New York (in press).

Articles

  • Zhang, Z., J. Friedlander, Y. Eroglu, A. Zigman, F. Moore, and T. Lamkin. 2011. Colonic mass, adenocarcinoma of the colon.  J. Ped. Gastroent. Hep. And Nutrit. Mar;52(3):253.
  • Moore, F.R., S. Bergman, and K.R. Geisinger. 2010. Metastatic hepatocellular carcinoma mimicing acinic cell carcinoma of the parotid gland – a case report.  Acta Cytologica 54(5):889-892.

Posters

  • Lebel, K., A. Tyropolis, F. Moore, S. Pleuger, and G. Tsongalis. 2011. A fragile X screening program utilizing the Amplidex FMR-1 and mPCR-CE assays by Assuragen.  Journal of Molecular Diagnostics 13(6):720.
  • Moore, F.R, F. Yang, and R.D. Press. 2010. WT1 RNA as a marker of minimal residual disease in acute myeloid leukemia.  Journal of Molecular Diagnostics 12(6):872.
  • Rattray, R., F.R. Moore, and R.D. Press.  2010.  A multi-tiered RT-PCR approach to detection, subtyping, and oseltamivir resistance testing of Influenza viruses.  Journal of Molecular Diagnostics 12(6):876.
 
Back